These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 26956691)

  • 21. A controlled trial of nonoxynol 9 film to reduce male-to-female transmission of sexually transmitted diseases.
    Roddy RE; Zekeng L; Ryan KA; Tamoufé U; Weir SS; Wong EL
    N Engl J Med; 1998 Aug; 339(8):504-10. PubMed ID: 9709043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of multipurpose technologies products for pregnancy and STI prevention: update on polyphenylene carboxymethylene MPT gel development†.
    Weitzel M; North BB; Waller D
    Biol Reprod; 2020 Aug; 103(2):299-309. PubMed ID: 32469052
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ensuring successful development and introduction of multipurpose prevention technologies through an innovative partnership approach.
    Young Holt B; Romano J; Manning J; Hemmerling A; Shields W; Vyda L; Lusti-Narasimhan M
    BJOG; 2014 Oct; 121 Suppl 5():3-8. PubMed ID: 25335832
    [No Abstract]   [Full Text] [Related]  

  • 24. Commentary on research to improve contraceptive and multipurpose prevention technologies.
    Speidel JJ; Townsend J; Williams E; Quam J; Thompson KMJ
    Contraception; 2020 Mar; 101(3):148-152. PubMed ID: 31917180
    [No Abstract]   [Full Text] [Related]  

  • 25. [Current status of the female condom in Africa].
    Deniaud F
    Sante; 1997; 7(6):405-15. PubMed ID: 9503499
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Barriers to preventing unintended pregnancies and sexually transmitted infections as experienced by women in Fort Dauphin, southeast Madagascar.
    Robson L; Morris J; Andriatsihosena M
    Eur J Contracept Reprod Health Care; 2015; 20(6):451-62. PubMed ID: 26153656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contraceptive choice, sexually transmitted diseases, HIV infection, and future fecundity.
    Cates W
    J Br Fer Soc; 1996; 1(1):18-22. PubMed ID: 12346972
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multipurpose prevention technologies: biomedical tools to prevent HIV-1, HSV-2, and unintended pregnancies.
    Thurman AR; Clark MR; Doncel GF
    Infect Dis Obstet Gynecol; 2011; 2011():1-10. PubMed ID: 21836811
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The dual goals of reproductive health.
    Cates W
    Netw Res Triangle Park N C; 1996; 16(3):3 p. PubMed ID: 12293921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multipurpose Prevention Technologies: Oral, Parenteral, and Vaginal Dosage Forms for Prevention of HIV/STIs and Unplanned Pregnancy.
    Young IC; Benhabbour SR
    Polymers (Basel); 2021 Jul; 13(15):. PubMed ID: 34372059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of hormonal contraception and pregnancy on sexually transmitted infections and on cervicovaginal microbiota in african sex workers.
    Borgdorff H; Verwijs MC; Wit FW; Tsivtsivadze E; Ndayisaba GF; Verhelst R; Schuren FH; van de Wijgert JH
    Sex Transm Dis; 2015 Mar; 42(3):143-52. PubMed ID: 25668647
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The need for multipurpose prevention technologies in sub-Saharan Africa.
    Karim SA; Baxter C; Frohlich J; Karim QA
    BJOG; 2014 Oct; 121 Suppl 5(0 5):27-34. PubMed ID: 25335838
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tailored intervention to increase dual-contraceptive method use: a randomized trial to reduce unintended pregnancies and sexually transmitted infections.
    Peipert JF; Redding CA; Blume JD; Allsworth JE; Matteson KA; Lozowski F; Mayer KH; Morokoff PJ; Rossi JS
    Am J Obstet Gynecol; 2008 Jun; 198(6):630.e1-8. PubMed ID: 18395692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contraception and sexually transmitted infections.
    Sheary B; Dayan L
    Aust Fam Physician; 2005 Oct; 34(10):869-72. PubMed ID: 16217576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The future of multipurpose prevention technology product strategies: understanding the market in parallel with product development.
    Romano JW; Van Damme L; Hillier S
    BJOG; 2014 Oct; 121 Suppl 5():15-8. PubMed ID: 25335835
    [No Abstract]   [Full Text] [Related]  

  • 36. Gynecologic care and family planning for HIV-infected women.
    Aaron E; Levine AB
    AIDS Read; 2005 Aug; 15(8):420-3,426-8. PubMed ID: 16110557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interest in multipurpose prevention of HIV and pregnancy: perspectives of women, men, health professionals and community stakeholders in two vaginal gel studies in southern Africa.
    Woodsong C; Musara P; Chandipwisa A; Montgomery E; Alleman P; Chirenje M; Chipato T; Martinson F; Hoffman I
    BJOG; 2014 Oct; 121 Suppl 5():45-52. PubMed ID: 25335840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sexually transmitted infections in pediatric renal transplant recipients: Time to take notice!
    Ashoor I; Aviles D; Pasternak R; Vehaskari VM
    Pediatr Transplant; 2015 Sep; 19(6):584-7. PubMed ID: 26108149
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Moving the Message Beyond the Methods: Toward Integration of Unintended Pregnancy and Sexually Transmitted Infection/HIV Prevention.
    Steiner RJ; Liddon N; Swartzendruber AL; Pazol K; Sales JM
    Am J Prev Med; 2018 Mar; 54(3):440-443. PubMed ID: 29287938
    [No Abstract]   [Full Text] [Related]  

  • 40. Contraception choice and sexually transmitted disease.
    Barnhart KT; Sondheimer SJ
    Curr Opin Obstet Gynecol; 1993 Dec; 5(6):823-8. PubMed ID: 8286696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.